After 18 years, will vTv Therapeutics’ Alzheimer’s drug sink or swim?
vTv Therapeutics has spent nearly two decades advancing its Alzheimer’s drug, and results from two Phase 3 trials are expected in 2018.
vTv Therapeutics has spent nearly two decades advancing its Alzheimer’s drug, and results from two Phase 3 trials are expected in 2018.